Skip to main navigation Skip to search Skip to main content

Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe

  • Kimberley S. M. Benschop*
  • , Eeva K. Broberg
  • , Emma Hodcroft
  • , Dennis Schmitz
  • , Jan Albert
  • , Anda Baicus
  • , Jean-Luc Bailly
  • , Gudrun Baldvinsdottir
  • , Natasa Berginc
  • , Soile Blomqvist
  • , Sindy Böttcher
  • , Mia Brytting
  • , Erika Bujaki
  • , Maria Cabrerizo
  • , Cristina Celma
  • , Ondrej Cinek
  • , Eric C. J. Claas
  • , Jeroen Cremer
  • , Jonathan Dean
  • , Jennifer L. Dembinski
  • Iryna Demchyshyna, Sabine Diedrich, Susanne Dudman, Jake Dunning, Robert Dyrdak, Mary Emmanouil, Agnes Farkas, Cillian de Gascun, Guillaume Fournier, Irina Georgieva, Ruben Gonzalez-Sanz, Jolanda van Hooydonk-Elving, Anne J. Jääskeläinen, Ruta Jancauskaite, Kathrin Keeren, Thea K. Fischer, Sidsel Krokstad, Lubomira Nikolaeva-Glomb, Ludmila Novakova, Sofie E. Midgley, Audrey Mirand, Richard Molenkamp, Ursula Morley, Joël Mossong, Svajune Muralyte, Jean-Luc Murk, Trung Nguyen, Svein A. Nordbø, Riikka Österback, Suzan Pas, Laura Pellegrinelli, Vassiliki Pogka, Birgit Prochazka, Petra Rainetova, Marc van Ranst, Lieuwe Roorda, Isabelle Schuffenecker, Rob Schuurman, Asya Stoyanova, Kate Templeton, Jaco J. Verweij, Androniki Voulgari-Kokota, Tytti Vuorinen, Elke Wollants, Katja C. Wolthers, Katherina Zakikhany, Richard Neher, Heli Harvala, Peter Simmonds
*Corresponding author for this work
  • National Institute of Public Health and the Environment
  • European Centre for Disease Prevention and Control
  • University of Basel
  • Karolinska Institutet
  • Cantacuzino, Bucharest, Romania
  • CHU de Clermont-Ferrand
  • Landspitali University Hospital
  • National laboratory of Health, Environment and Food, Ljubljana, Slovenia
  • National Institute for Health and Welfare
  • Robert Koch-Institut
  • Public Health Agency of Sweden
  • National Public Health Center, Budapest, Hungary
  • Instituto de Salud Carlos III
  • UK Health Security Agency
  • Charles University
  • Leiden University Medical Center
  • University College Dublin
  • World Health Organization
  • Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine
  • University of Oslo
  • Institut Pasteur Helleniqe
  • Laboratoire National de Santé
  • National Center of Infectious and Parasitic Diseases Bulgaria
  • Microvida, Breda, the Netherlands
  • University of Helsinki
  • National Public Health Surveillance Laboratory, Vilnius, Lithuania
  • University of Copenhagen
  • Norwegian University of Science and Technology
  • Czech National Institute of Public Health
  • WHO Regional Office for Europe
  • Erasmus MC
  • ETZ Elisabeth
  • University of Turku
  • University of Milan
  • Austrian Agency for Health and Food Safety GmbH
  • KU Leuven
  • Department of Internal Medicine and Infectious Diseases, Maasstad Ziekenhuis, Rotterdam, Netherlands
  • Hospices civils de Lyon
  • University Medical Center Utrecht
  • National Health Services Scotland, Edinburgh, Scotland, UK
  • Amsterdam UMC - University of Amsterdam
  • University College London
  • National Health Service, Colindale
  • University of Oxford

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In 2018, an upsurge in echovirus 30 (E30) infections was reported in Europe. We conducted a large-scale epidemiologic and evolutionary study of 1,329 E30 strains collected in 22 countries in Europe during 2016-2018. Most E30 cases affected persons 0-4 years of age (29%) and 25-34 years of age (27%). Sequences were divided into 6 genetic clades (G1-G6). Most (53%) sequences belonged to G1, followed by G6 (23%), G2 (17%), G4 (4%), G3 (0.3%), and G5 (0.2%). Each clade encompassed unique individual recombinant forms; G1 and G4 displayed >2 unique recombinant forms. Rapid turnover of new clades and recombinant forms occurred over time. Clades G1 and G6 dominated in 2018, suggesting the E30 upsurge was caused by emergence of 2 distinct clades circulating in Europe. Investigation into the mechanisms behind the rapid turnover of E30 is crucial for clarifying the epidemiology and evolution of these enterovirus infections.
Original languageEnglish
Pages (from-to)1616-1626
Number of pages11
JournalEmerging infectious diseases
Volume27
Issue number6
DOIs
Publication statusPublished - 1 Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe'. Together they form a unique fingerprint.

Cite this